酸通过调节HER2/AKT/mTOR信号通路来缓解葡萄糖皮质激素诱导的骨质疏松症
An-Na Xie1, Sun-Zheng-Yuan Zhang1, Yu Zhang1
1Laboratory of Science and Technology Center, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China.
Journal of integrative medicine
|August 31, 2025
概括
酸 (CGA) 通过改善骨健康和向骨细胞,有效治疗葡萄糖皮质醇诱导的骨质疏松症 (GIOP). 它调节HER2/AKT/mTOR通路,为GIOP提供一种潜在的治疗策略.
科学领域:
- 生物化学
- 细胞生物学
- 药理学
背景情况:
- 葡萄糖皮质激素诱导的骨质疏松症 (GIOP) 是长期使用葡萄糖皮质激素的一个严重并发症.
- 酸 (CGA) 是一种来自传统中医药的多,具有抗氧化特性和潜在的抗骨质疏松作用.
研究的目的:
- 在GIOP小鼠模型中研究CGA的疗效.
- 在体外和体内探索CGA对GIOP治疗作用的分子机制.
主要方法:
- 在使用微型CT,组织学和血清分析的德克萨梅他松诱导的GIOP小鼠模型中评估了CGA的保护作用.
- 使用网络药理学来预测治疗目标和途径.
- 使用体外测定 (染色,流细胞测量,RT-qPCR,西方抹杀) 来验证MLO-Y4细胞中的机制.
主要成果:
- 在小鼠中,CGA治疗逆转了甲诱导的骨质损失,改善了骨细胞形态.
- 网络药理学确定ERBB2 (HER2),卡斯巴-3和其他蛋白质为核心点,涉及ERBB,AKT和mTOR途径.
- 在体外研究证实,CGA通过激活HER2/AKT/mTOR通路在MLO- Y4细胞中增强骨形成,促进自,并抑制细胞亡.
结论:
- 酸对GIOP具有显著的抗骨质疏松作用.
- 部分通过向骨细胞和调节HER2/AKT/mTOR信号通路而起作用.
相关概念视频
GPCRs Regulate Adenylyl Cylase Activity
5.9K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.9K
TGF - β Signaling Pathway
7.6K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.6K
Glucagon-like Receptor Agonists
416
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
416
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
201
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
201
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K


